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Abstract
Background—Efficacious interventions to reduce drug use and its consequences for club drug 
using populations are not apparent in the literature. We tested interviewer-(CAPI) and self-
administered (ACASI) comprehensive health and social risk assessments as distinct interventions 
compared to waitlist control.
Methods—750 men and women ages 18-39 with multidrug use and heterosexual behavior were 
randomized in equal proportions to the three conditions. Instrumentation included well-tested 
measures of drug use, risky sex, mental distress and substance dependence.
Results—The sample was 56% male; mean age=25. Reported risk behaviors and health 
consequences did not differ by assessment modality. Adjusted HLM analyses showed a significant 
main effect of assigned condition on all outcomes. CAPI participants had greater reductions in 
drug use, risky sex, mental distress and substance dependence symptoms, and greater increases in 
abstinence, compared to ACASI intervention or control participants at 12 months, except that the 
CAPI and ACASI conditions had similar efficacy for reductions in drug use. Effect sizes for CAPI 
versus ACASI participants were d=0.2-0.3, and between CAPI and controls d=0.2-0.4. Effect sizes 
for improved outcomes between ACASI compared to controls were small to non-significant.
Conclusions—The study established the therapeutic benefit of interviewer interaction in 
reducing risky behavior among this young drug using population. The study demonstrated the 
efficacy and acceptability of a low threshold intervention in reducing drug use, sexual risk and 
related co-morbidities among a not-in-treatment young adult population that exhibits severe and 
complex levels of drug use, but that is also highly resistant to intervention.
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1. Introduction
Young adults who predominate in electronic dance music (EDM) and other nightclub 
subcultures are especially vulnerable to mixing numerous drugs during typical binges on 
weekends and at special events (Kurtz, Inciardi, Surratt, & Cottler, 2005; Kurtz, Surratt, 
Buttram, Levi-Minzi, & Chen, 2013; Owen, 2003; Silcott, 1999). The term “club drugs” 
traditionally refers to illicit stimulant and hallucinogenic drugs commonly used to enhance 
the club experience, including MDMA, powder cocaine, LSD, ketamine and GHB (National 
Institute on Drug Abuse, 2009; Parsons, Grov, & Kelly, 2009; Reynolds, 1998), but these 
have expanded over the years to include psychoactive prescription medications (Kelly & 
Parsons, 2007; Kelly, Wells, Pawson, LeClair, & Parsons, 2014; Kurtz et al., 2005; Kurtz, 
Surratt, Buttram, Levi-Minzi, & Chen, 2013), and an ever-evolving range of synthetic 
psychedelic and stimulant “designer” drugs (German, Fleckenstein, & Hanson, 2014; 
Musselman & Hampton, 2014).
The intensity and complexity of club-goers' substance use puts them at high risk for 
numerous health and social problems, including: tolerance, dependence, overdose, and 
chronic psychiatric symptoms, (Cottler, Womack, Compton, & Ben-Abdallah, 2001; Kurtz 
et al., 2013; Kurtz, Surratt, Levi-Minzi, & Mooss, 2011; Nicholi, 1983; Shifano, Di Furia, 
Gorza, Minicuci, & Bricolo, 1998; Parrott, Milani, Parmar, & Turner, 2001); difficulties with 
peer and other social relationships (Chinet, Stephan, Zobel, & Halfon, 2007; Singer, Linares, 
Ntiri, Henry, & Minnes, 2004); drunk/drugged driving (Voas, Johnson, & Miller, 2013), 
criminal activity and violent victimization (Kurtz, 2012; Kurtz, Inciardi, & Pujals, 2009); 
sexual risk behaviors (Buttram & Kurtz, 2015a; Buttram & Kurtz, 2016; Novoa, Ompad, 
Wu, Vlahov, & Galea, 2005; Sterk, Klein, & Elifson, 2008) and higher rates of sexually 
transmitted infections (STI; Mitcheson, McCambridge, Byrne, Hunt, & Winstock, 2008).
The wide-ranging adverse consequences of substance use among this young population 
require intervention approaches that are feasible to implement, acceptable to the population, 
and effective in producing behavioral change. However, the use of euphoric and 
hallucinogenic drugs is widely viewed in the club culture as fun and fashionable, and few 
recognize the problematic aspects of substance use (Kurtz, et al., 2013; Whittingham et al., 
2009; Abdulrahim & Bowden-Jones, 2015). As a result, there is pervasive resistance to 
participation in formal interventions. Moreover, club scene participants tend to be suspicious 
of or disinterested in drug use and sexual risk prevention messages delivered by 
governmental or health authorities; peers and internet sites are more trusted sources of this 
information (Carlson, Falck, McCaughan, & Siegal, 2004; Falck, Carlson, Wang & Siegal, 
2004).
Few controlled intervention studies for club drug using populations are apparent in the 
literature. Researchers have found mixed success with the dissemination of educational 
materials (Whittingham et al., 2009), although one study of peer-delivered health messages 
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showed promise (Sillins, Bleeker, Simpson, Dillon, & Copeland, 2013). Two large trials 
comparing motivational enhancement therapy to educational campaigns found moderate 
post-intervention reductions in ecstasy use in both randomized conditions (Marsden et al., 
2006; Norberg et al., 2014). Brief screening and referral interventions, while effective for 
alcohol use, have not demonstrated much success with diverse samples of drug users (Saitz 
2014; White et al., 2015; Young et al., 2014).
To address this gap, we tested the efficacy of two brief assessment intervention conditions 
compared to a waitlist control in reducing drug and sex-related risk behavior among young 
adults with multidrug use in the EDM nightclub culture. This intervention approach emerged 
from an earlier natural history study of young men and women in the club scene with 
complex levels of drug use, which found that participation in periodic interviewer-
administered comprehensive health and social risk assessments induced participants to 
sharply reduce their substance use and sexual risk behaviors over 18 months (Kurtz et al., 
2013). Similar reactive effects of research study and/or clinical assessments, attributed to 
consciousness raising, self-monitoring, increased self-awareness, and/or self-efficacy, have 
been recognized since at least the mid-1970s (Clifford & Maisto, 2000; Epstein et al., 2005; 
Lightfoot, Comulada, & Stover, 2007). In fact, Clifford, Maisto, & Davis (2007) noted the 
similarities of such assessments to formal substance abuse treatment, as both combine 
problem evaluation with perceived professional interest in one's well-being.
Given the robust findings of the natural history study, and the challenges in designing 
interventions for the population noted earlier, evaluating a potentially scalable, single-
session assessment-based intervention approach in a controlled trial appeared particularly 
promising. At the same time, computerized, self-administered interventions (not necessarily 
assessment-based) have emerged as useful tools for psychotherapy (Newman, 2004); 
treating insomnia (Schaffer, 2009), depression (McKendree-Smith, Floyd, & Scogin, 2003), 
and cannabis use disorder (Budney et al. 2015); and reducing sexual risk behaviors and STI 
incidence (Noar, Black, & Pierce, 2009), though there is mixed evidence regarding their 
effectiveness compared to clinician-delivered treatments (Greist et al., 2002 [clinician 
superior]; Budney et al., 2015 [clinican-computer equal]). Thus, we tested interviewer- and 
self-administered modes of assessment as distinct interventions to examine potential 
differences in their efficacy. This approach essentially tests the value added by the relational 
interview interaction in producing behavioral change, which aligns with a social influences 
perspective (Bandura, 1986).
2. Methods
2.1. Study design
The three-armed randomized controlled trial was designed to recruit a sample of 750 
participants in order to achieve 80 percent power to detect 0.2 effect size reductions in 
primary outcomes - past 90-day substance use and condomless anal/vaginal sex frequencies 
– within intervention condition, and 0.3 effect size differences between conditions, assuming 
20% attrition over the 12 month follow-up period. Drug/heavy alcohol abstinence, mental 
distress, and drug dependence symptoms were specified as secondary outcomes. The 
primary hypothesis was that participants assigned to the computer-assisted personal 
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interview (CAPI) and audio computer-assisted self-interview (ACASI) assessment 
intervention conditions would reduce their sexual risks and substance use to a similar degree 
and to a significantly greater extent than those assigned to a waitlist control condition across 
all outcome measures. The protocol is registered with ClinicalTrials.gov #NCT01362634.
2.2. Site
Miami-Dade County, Florida is a diverse community of 2.6 million people, of whom 66.2% 
are Hispanic, 18.9% Black and 14.8% White (U.S. Census Bureau, 2015). Specific to the 
EDM nightclub scene, Miami is an international destination for partying, sexual tourism, 
and club drug use – setting trends that are emulated and replicated globally (Brandt, 2003; 
Perrone, 2009).
2.3. Sampling plan
Participants (N=750) were recruited between September 2011 and November 2014 through 
respondent-driven sampling (RDS; Heckathorn, 1997). Seeds (initial respondents) were 
recruited through outreach at local nightclubs and existing contacts in the club culture. Each 
seed and subsequent study participant was provided with recruitment coupons to give to 
other drug users in their social network, with the understanding that they would earn $50 for 
the recruitment of each additional eligible respondent. Based upon recruitment patterns in 
the prior natural history study, steering incentives (Heckathorn et al., 2002) of an additional 
$10 were implemented to reward the recruitment of women and African Americans. Each 
participant-recruiter was limited to five coupons to prevent a few participants with large 
social networks from biasing the overall sample toward those with similar demographic and 
drug using profiles.
Inclusion criteria were: 1) ages 18-39; 2) heterosexual vaginal and/or anal sex in the past 90 
days; 3) use of club drug(s), defined as powder cocaine, MDMA, LSD, methamphetamine, 
GHB and/or ketamine, at least three times in the past 90 days; 4) non-medical use of a 
psychoactive prescription medication in the past 90 days; 5) attendance at large local 
nightclubs at least once per month; 6) residence in metropolitan Miami with no plans to 
move away in the next year; and 7) willingness to provide a mailing address, personal 
telephone number, and email address or social media profile.
Eligibility was restricted to men and women who reported recent heterosexual behavior 
because the sexual risk reduction component of the intervention would need to be carefully 
targeted to be meaningful; men and women who also reported same-gender sex were not 
excluded. Substance use criteria were selected to match those in the earlier natural history 
study, and to ensure that drug use was sufficiently frequent and complex as to indicate the 
need for intervention. Pregnant women and anyone currently enrolled in a substance abuse 
treatment program were excluded. Follow-up interviews were completed in November 2015.
2.4. Staffing
Field staff were age-peers of the target population with at least a Bachelor's degree, one year 
of research experience, and an expressed commitment to substance abuse research. They 
were trained in the study recruitment procedures, human subjects protections, data collection 
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instruments, intervention protocols, and completed requirements for State of Florida 
certification as HIV test counselors.
2.5. Procedures
The study was conducted at a field office located in a standard business office building near 
the center of the primary transportation routes of the County. Potential enrollees responding 
to recruitment messages or coupons were screened for eligibility by telephone. Screening 
instruments included queries about pseudo drugs and other non-eligibility measures to 
prevent dissemination of the actual criteria. Those who were eligible and interested in 
participating were scheduled for enrollment at the field office. The enrollment visit included 
five elements: 1) eligibility rescreening; 2) written informed consent, including a description 
of the study aims and the three intervention conditions, using procedures approved by the 
university's institutional review board; 3) collection of locator information; 4) HIV brief 
counseling and rapid test administration (721 tested, 23 refused, 6 self-reported HIV+ 
status); and 5) training in the RDS recruitment procedures. Enrollees were paid $30 for their 
time and travel expenses, and scheduled for the baseline assessment and intervention visit 
within the next 1-2 weeks.
Enrollees who did not return for the baseline visit were replaced. At baseline, all participants 
completed a brief risk behavior inventory (RBI; 17 substance use frequency items and 8 
sexual behavior items) assessing primary outcomes using an ACASI-based instrument that 
was designed to minimize reactive effects and took a median of 12 minutes to complete. 
Participants were randomized immediately thereafter in 1:1:1 ratio to the three study arms: 
1) an interviewer-administered comprehensive health and social risk assessment intervention 
(CAPI Intervention); 2) a self-administered assessment intervention with identical 
instrumentation (ACASI Intervention); and 3) a waitlist control condition (Control). 
Randomization was based on a computer-generated random number table specified by the 
total sample size and equal probability of assignment to the three conditions. Sequentially-
numbered opaque envelopes containing the arm assignment designations were prepared in 
the research office and delivered in batches to the field office director. Field staff requested 
the next envelope in sequence following each participant's completion of the baseline RBI; 
the participant opened the envelope in the presence of the staff member. All participants 
received free condoms and a $50 stipend upon completion of these baseline activities, which 
lasted approximately 30 minutes. During this same visit and immediately after 
randomization, those assigned to the CAPI or ACASI arms continued with the intervention 
protocols (see Interventions, below).
2.6. Interventions
The comprehensive health and social risk assessment interventions, which may be found at 
http://arsh.nova.edu/publications/forms/intervention-instrumentation.pdf, included identical 
instrumentation for CAPI and ACASI administration, and were programmed using the 
QDS™ Questionnaire Development System (Nova Research 2009). The programming 
included clear skip patterns, well-defined value ranges to bound answer selection, checks for 
consistency with answers to earlier questions on the same topic, and required a response 
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entry (including “don't know” and “refuse to answer” choices) before moving on to the next 
question.
The CAPI intervention was administered in a private office by a trained interviewer who 
read the questions verbatim from the QDS™ screens to the participant and recorded their 
responses on a laptop computer. Research assistants were trained to hear and record 
participants' responses to assessment items without signaling judgment, discomfort, surprise 
or emotion, as well as avoiding extraneous conversation or deviating from the interview 
instrument. The ACASI intervention was loaded onto one of several desktop computers that 
were housed in private cubicles; participants' read and/or listened to the questions and 
recorded their own responses.
The interventions were based upon the assessments used for the natural history study, but 
enhanced in several areas to increase participants' critical awareness of the health and social 
risks posed by substance use and condomless sex. The core instrumentation was the Global 
Appraisal of Individual Needs (GAIN, v. 5.4; Dennis, 2006), which has eight core sections 
(background, substance use, physical health, sexual risk behaviors, mental health, 
victimization, criminal justice involvement, and education/work/financial stability), with 
each containing questions on recency of problems, breadth of symptoms, and recent (90 day) 
and lifetime prevalence in days or times. The items include scales for Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV)-based diagnoses (American 
Psychiatric Association, 1994). Psychometric studies have found Cronbach's alphas 
between .8 and .9. Behavior questions have demonstrated test-retest correlations over .8 
(Dennis, Rourke, Lennox, Campbell & Caddell, 1995).
For this study, the list of drugs was extended to include major classes of psychoactive 
prescription medications. The sexual behavior questions were expanded to include counts of 
total and condomless vaginal and anal sex events; number, gender and types of sex partners 
(primary vs. casual); substances used before or during sex; agreements and knowledge about 
monogamy in primary relationships; group sex behaviors; and knowledge of sex partners' 
HIV status. We also enhanced the assessment to include items focused on friendship 
characteristics and social support; social acceptability of various drug use and sexual 
behaviors; resilience, coping and distress tolerance; goal-setting and achievement; social 
activities and community involvement; and readiness to change substance use and sexual 
behaviors.
The baseline assessments (as well as the 12 month assessments for control arm participants) 
took a median of 76 minutes for ACASI participants and 89 minutes for CAPI participants 
to complete. The 12 month assessments for the intervention groups excluded life history 
items collected at baseline and took a median of 68 minutes to complete.
Fidelity monitoring. CAPI interviews were assigned to interviewers on the basis of schedule 
availability without regard to participant characteristics. All CAPI interventions were audio-
recorded for auditing and training. The first 5 interviews conducted by each interviewer were 
audited by non-project research staff who listened to the audio recording, re-keyed the 
interview to identify any errors, and noted any deviations from protocol. Following these 
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initial audits, two interviews per interviewer per month were audited to maintain the fidelity 
of the CAPI intervention. No baseline differences in outcome measures by interviewer were 
observed. ACASI assessments were examined by field staff for completeness and 
consistency of responses before the participant left the field office to allow participants to 
complete any unintentionally missed items and to clarify discrepant responses.
2.7. Follow-Up visits
At 3-, 6- and 12-months post-baseline, all participants again completed the ACASI-based 
RBI that measured primary outcome data. At 12-month follow-up, those assigned to the 
control condition received the CAPI assessment intervention, while those assigned to the 
CAPI and ACASI intervention conditions completed an interviewer-administered instrument 
that was similar to the intervention assessment, inclusive of secondary outcome data but 
exclusive of life history items. Using this design, data collection procedures were consistent 
at each wave and across arms, with the only difference that those assigned to the two 
intervention groups completed the CAPI or ACASI comprehensive health and social risk 
assessment at baseline. Respondents received $50 for their time and travel costs for each 
visit.
2.8. Measures
Demographic measures included age, gender, race/ethnicity, and education. Race/ethnicity 
was assessed by asking participants if they were Hispanic or Latino, followed by asking 
what race they considered themselves to be. Education was assessed based on high school 
completion vs. not.
Substance use measures included past 90-day frequencies, in days (“in the past 90 days, 
since [anchor point], how many days have you used any …”), of use of alcohol, marijuana, 
powder cocaine, ecstasy, LSD, other hallucinogens (e.g., psilocybin, PCP; ketamine; 2cx, 
DMT), methamphetamine, and heroin, as well as the non-medical use of prescription 
benzodiazepines, opioids, stimulants, antidepressants and antipsychotics. For descriptive 
reporting, baseline substance use measures were dichotomized into “yes” and “no”. For 
longitudinal analyses of substance use outcomes, we constructed a past 90-day composite 
club drug use measure equal to the sum of days of use of the four most prevalent club drugs: 
powder cocaine, ecstasy, and prescription benzodiazepines and opioids. The instrumentation 
also included a global measure of drug/heavy alcohol abstinence that was used in the 
efficacy analyses, “During the past 90 days, on how many days did you go without using 5 
or more drinks, marijuana, cocaine, or any other drug?”
Sexual behavior questions included counts of past 90-day sex partners and condomless 
vaginal and anal intercourse events. To assess potential infectious disease exposure, risky 
vaginal and/or anal sex was defined as condomless vaginal and/or anal intercourse in the 
context of a non-monogamous relationship or with a non-primary partner during the past 90 
days. For descriptive reporting, baseline risky sex measures were dichotomized into “yes” 
and “no”.
The GAIN includes the General Mental Distress Scale (GMDS), which includes past year 
DSM-IV symptom counts of depression (9 items), anxiety (12 items), and somatic disorders 
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(four items). Alpha reliability coefficients for the depression, anxiety, and somaticism 
subscales in this study were 0.882, 0.887, and 0.801, respectively. The GMDS is further 
reducible to classifications indicating clinical significance - subclinical, moderate, and 
severe (Dennis, 2006) - and was dichotomized into “severe” (seven or more symptoms) and 
“not severe” for descriptive purposes. Substance dependence was assessed by seven DSM-
IV symptoms during the past year (e.g., needing more drug to get the same effect; being 
unable to quit or cut down), and was dichotomized as “dependent” (three or more 
symptoms) or “not dependent” for descriptive reporting.
Victimization was assessed by affirmative responses to any of the following events: being 
attacked with a weapon or being beaten so as to cause bruises, cuts or broken bones 
(physical abuse); being forced to participate in sexual acts against one's will (sexual abuse); 
or being made to feel very bad about oneself or one's life (emotional abuse). Age of first 
instance of any type of abuse was dichotomized into “victimized before the age of 18” vs. 
not.
2.9 Data Analyses
Statistical analyses were performed using the procedures CORR, FREQ, MIXED, and 
GLIMMIX of SAS Version 9.3 (SAS Institute Inc., Cary, NC). There were no missing data 
on completed assessments, except for one ACASI participant who refused secondary 
outcome items and age of first victimization, and six ACASI participants who responded 
“don't know” to extent of recent abstinence. For the baseline to 3 month outcomes, there 
were 684 cases available for analysis; for baseline to 6 months, 669 cases; and for baseline 
to 12 months, 602 cases. All outcomes were examined on an intent-to-treat basis, and 
included all data available at the four study intervals. There were no differences in baseline 
characteristics or arm assignment between cases with (N=602) and without (N=148) 
complete follow-up data, and missing data patterns were nonmonotone.
Means, standard deviations, and frequencies were calculated for descriptive reporting. 
Except for substance dependence symptoms, distributions of outcome measures were 
positively skewed and required logarithmic transformations for longitudinal analyses. In 
accordance with the Consolidated Standards of Reporting Trials (CONSORT; Schultz, 
Altman, & Moher, 2010) statement, we report a summary of unadjusted outcomes by arm 
and study interval. Effect size estimates of individual-level change (unadjusted) were 
calculated from the mean difference between baseline and 12 month scores divided by the 
standard deviation of the change score, corrected by the correlation between time points 
(i.e., [(M1 - M2) / SD] / √(1 - r); Cohen, 1988). Statistics reported are based on log-
transformed measures, including Cohen's d effect size statistics and related 95% confidence 
intervals. Formulas for converting between F, eta2, and d were taken from Cohen (1988). We 
characterize these d statistics using Cohen's categories of ‘small’ (d =0.2), ‘medium’ (d = 
0.5), and ‘large’ (d =0.8) (Cohen, 1988).
Five hierarchical linear models (HLMs) were constructed to evaluate the efficacy of the 
interventions on outcomes. Two primary (club drug use and risky sex frequencies) and three 
secondary (days abstinent from drug/heavy alcohol use; mental distress and substance 
dependence symptoms) outcomes were pre-specified in the trial protocol. In accordance with 
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the study design, secondary outcomes at baseline were not collected among controls, as they 
did not complete a comprehensive assessment until 12 month follow-up. As pre-specified in 
the trial's protocol, we used the Markov chain Monte Carlo method for multiple imputations 
with weighted covariates (Little & Rubin, 2002) for missing data reconstruction of the 
baseline values of secondary outcomes for controls. Weighted covariates included history of 
DUI, intoxication, and treatment episodes; and diagnostic history of anxiety, depression, and 
post-traumatic stress disorder. The statistics reported for these variables are the averaged 
results across 50 imputations. We note that baseline values of secondary outcome measures 
could not be estimated using these procedures for control arm participants who did not 
complete a 12-month assessment.
Risky anal/vaginal sex incidences were analyzed using Poisson regression methods 
recommended for count data with random intercepts by maximum likelihood and with a 
robust variance correction (Allison, 2005). Random effects included subjects and time with 
an unstructured correlation matrix to allow for all possible correlations between the random 
intercept, random slope, and time. Models predicting primary outcomes included a time 
term, a quadratic time term, and time*arm interaction term. Using the Tukey-Kramer 
adjustment for multiple comparisons in HLM models, HLM models included contrast 
statements to determine effect size differences between arm conditions. Parameter estimates 
were adjusted for characteristics prognostic of outcomes (age; Pagano, Zemore, Onder & 
Stout, 2009) and gender and race/ethnicity subgroups in accordance with the CONSORT 
statement and NIH reporting requirements. When multicollinearity diagnostics of fitted 
models were examined, tolerances were .50 and above, indicating low concern of 
multicollinearity (Allison, 1999). The family-wise error rate for the two sets of outcomes 
was set at .05 (two tailed).
3. Results
3.1. Sample characteristics
Sample characteristics at baseline by intervention condition are shown in Table 1. On 
average, participants were 25.4 years of age (SD=5.4, range=18-39) and the large majority 
(85.3%) had completed high school. About half (56.1%) were male; the racial/ethnic 
composition reflected Miami-Dade County's population: 65.7% Hispanic; 20.4% Black, 
11.6% White and 2.3% other race/ethnicity. In the 90 days prior to baseline, large majorities 
(88% or more) endorsed the use of alcohol, marijuana, cocaine, MDMA, benzodiazepines 
and/or opioid analgesics; about half used LSD, other hallucinogens and/or prescription 
stimulants; and more than 20% endorsed methamphetamine, heroin, and prescription 
antipsychotics and/or antidepressants.
The sample had an average of 6.9 (SD=13.3; median = 3) sex partners in the past 90 days; 
more than half had condomless vaginal sex, and more than one-quarter condomless anal sex, 
in non-monogamous relationships or with casual partners. About half (51%) reported 
symptoms of severe mental distress and 68.8% met DSM-IV criteria for substance 
dependence. Three out of four (74.5%) had histories of victimization, with 58.7% suffering 
abuse before the age of 18. The intervention groups were not significantly different at 
baseline on demographics, substance use, sexual behaviors, or psychiatric comorbidities.
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3.2 Enrollment, retention and adverse events
The participant flow chart is shown in Figure I. The most common reasons for failing the 
initial eligibility screen (N=1326) were: drug use threshold (64.9%); sexual behavior 
threshold (21.6%); lack of intention to remain in the Miami area for 12 months (14.2%); age 
(8.4%); clubbing frequency threshold (6.9%); and recent enrollment in a substance abuse 
treatment program (3.5%), or some combination of these. Of the 750 men and women 
randomized into the study: 557 participants (74.3%) completed all four assessments; 122 
(16.3%) completed baseline plus two follow-ups; 40 (5.3%) completed baseline plus one 
follow-up; and 31 (4.1%) completed only the baseline assessment. Participants missing one 
or more assessments did not differ from those with complete data in terms of age, gender, 
race/ethnicity, victimization history, or primary or secondary outcome measures at baseline. 
Attrition rates were similar across conditions.
Eleven participants withdrew from the study after baseline assessment for various reasons, 
including scheduling conflicts with employment or moving away from the area. Twenty 
participants were withdrawn from the study because they became members of vulnerable 
population groups for whom approvals for participation were not sought (i.e., pregnant 
women and prisoners). All other participants lost to follow-up were due to loss of contact 
with study staff. Although a number of participants experienced drug treatment admissions 
and medical problems over the course of the study, no adverse events were attributable to 
study participation. Two serious adverse events (deaths) occurred, but neither was related to 
study participation.
3.3 Study outcomes
Table 2 presents the means and standard deviations for study outcomes (unadjusted) by 
condition at each assessment point, together with the mean changes from baseline to 12 
months and the corresponding effect sizes. Large effect sizes (d=0.82-0.89) for the 
composite club drug use measure were found for both the CAPI and ACASI intervention 
conditions. Small to medium effect sizes (d=0.20-0.54) were found for the primary sexual 
risk and the secondary outcome measures in both intervention conditions, except that only 
the CAPI condition showed a significant increase in the number of days abstinent. In 
contrast, the effect sizes for risk reduction in the control condition were medium for the 
primary composite drug use outcome, small for the primary sexual risk outcome, and 
nonsignificant for secondary outcomes. In terms of clinical significance, participants in the 
CAPI intervention reported reductions in substance dependence and mental distress 
symptoms, on average, to below important diagnostic thresholds (3 or more substance 
dependence and 7 or more mental distress symptoms). Participants in the ACASI arm 
reported reductions in mental distress and substance dependence symptoms to about the 
clinically-significant cut points for these comorbidities, and those in the control group 
experienced no abatement of symptoms.
The results showing the efficacy of the two brief assessment interventions compared to 
controls on primary and secondary outcomes are shown in Table 3. Controlling for pre-
specified model covariates, the HLM analyses show a significant main effect of arm on 
primary and secondary outcomes. CAPI participants showed greater reductions in club drug 
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use and risky vaginal sex frequencies, and mental distress and substance dependence 
symptoms, and greater increases in days abstinent from drug/heavy alcohol use, compared to 
those assigned to the ACASI intervention or control conditions, except that the CAPI and 
ACASI conditions had similar efficacy for reduction in club drug use frequency. Effect sizes 
for the greater improvements among CAPI versus ACASI participants were small (d = 
0.2-0.3) and between CAPI and controls small to medium (d = 0.2-0.4). Effect sizes for 
improved outcomes in the ACASI arm compared to controls were small for club drug use 
frequency and non-significant for risky vaginal sex frequency. On secondary outcomes, 
ACASI outperformed the control condition by small (d=0.2) effect size differences in days 
abstinence and substance dependence symptoms, but no difference was found for mental 
distress symptoms. Thus, we found support for our hypothesis of significantly greater 
reductions in substance use and sexual risk behaviors among participants assigned to either 
intervention in comparison to waitlist controls, but only partially, as the CAPI intervention 
was more efficacious than the ACASI modality across four of five measures.
Collection of primary outcome data at four assessment periods allowed for the examination 
of changes in those outcomes over time in the sample overall, changes in the rate of change 
over time (time2), and whether the rate of change differed by condition (i.e. time X arm 
interaction). For risky vaginal sex frequency, the rate of change was non-linear, with the 
greater change in the initial follow-up period, and was more persistent among intervention 
groups compared to controls. There were no main effects of age, gender, or race/ethnicity on 
baseline measures of study outcomes.
4. Discussion
4.1 Efficacy of comprehensive assessments as interventions
Our primary hypothesis was partially confirmed, as the HLM analyses showed the 
interviewer-administered assessment intervention to be superior to the control group by 
meaningful margins across all outcomes. Most importantly, participants in the CAPI 
intervention reported reductions in substance dependence and mental distress symptoms to 
below clinically significant levels. However, contrary to our hypothesis, the ACASI 
condition showed lower efficacy, with small to non-significant effects compared to the 
control condition.
The effect sizes for reductions in drug use frequency and substance dependence symptoms 
in the CAPI arm approximate those reported in the parent natural history study of the same 
population (Kurtz et al., 2013). Taken together, these studies provide firm empirical support 
for the beneficial intervention effects of interviewer-administered comprehensive health and 
social risk assessments for not-in-treatment young adult drug users. Although ACASI 
showed modest efficacy compared to the controls on some outcome measures, it appears that 
interviewer interaction accounts for the major difference in assessment effects.
Although the precise mechanism of action is unclear, the interpersonal interviewer 
interaction likely plays a role in improving participants' processing and retention of 
assessment items, as well as providing a backdrop of empathy, tolerance, and openness, and 
the opportunity for verbal reflection on assessment items. We believe that comparisons with 
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computer- vs. professional therapist-delivered intervention trials of behavioral therapies 
(e.g., Budney et al., 2015) are not especially relevant to these findings. Our study targeted a 
sample resistant to intervention and was situated outside of a therapeutic setting. Participants 
were randomized to an experience of either self-recording their behaviors, attitudes and 
social experiences on a computer, or to verbalizing them to a non-judgmental, non-
professional age peer. Based on prior qualitative investigations into study subjects' similar 
experiences of interviewer-administered assessments (Kurtz et al., 2013; Buttram & Kurtz, 
2015b), we believe that participants often perceive interviewers as concerned for their well-
being and derive personal satisfaction or motivation to change from the positive relational 
aspect of the interview experience.
Certainly, it may be desirable to minimize reactive effects of assessments in many research 
studies. However, the overarching goal of this study was to find an acceptable, feasible and 
efficacious intervention approach for not-in-treatment young adults with complex patterns of 
multidrug use. Although an interviewer-administered assessment modality may be more 
difficult to scale up compared to a self-administered approach, this study nevertheless 
demonstrates the efficacy of a single session intervention that is acceptable to the target 
group. Next steps should include testing this intervention in settings where members of this 
population are routinely found, such as drug and DUI diversion programs, STI clinics, 
college campuses and social service agencies.
4.2. Effects of study participation and assessment modality on outcome measures
Our study findings advance the science of behavioral research among people who use drugs 
in a number of other areas. First and foremost, the study responds to important gaps in the 
literature regarding the effects of research study assessments on outcomes by including both 
a control group and a modality comparison in a randomized design (Kurtz, Stall, Buttram, 
Surratt, & Chen, 2013; Worden & McCrady, 2015). The inclusion of the waitlist control arm 
allows us to estimate, among a large sample of not-in-treatment young adults with complex 
multidrug use, the influences of widely recognized but rarely measured factors on substance 
use and sexual risk behavior outcomes: research study enrollment and participation, data 
collection, regression to the mean, readiness to change, and spontaneous remission. In the 
present study, all participants were also offered voluntary HIV counseling and testing, and 
uptake was high.
The effect size for reduction in drug use was in the medium range for control group 
participants, but there were not significant improvements in measures of abstinence, mental 
distress or substance dependence symptoms. Unfortunately, our study design does not enable 
us to tease out specific reasons for reduction in the primary drug use outcome measure 
among controls. Large-scale randomized studies with sufficient power to examine end-point 
differences with no baseline or interim data collection from the control group would be 
needed to distinguish the effects of even minimal data collection from other study 
participation influences.
In terms of the effects of assessment modality on data validity, we found no differences 
between the CAPI and ACASI arms on any baseline measures of demographics, health risk 
behaviors, or health problems. This finding is at odds with some research that shows ACASI 
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to increase the reporting of sensitive and/or stigmatizing behaviors, such as drug use (Des 
Jarlais et al., 1999; Newman et al., 2002) and sexual behaviors (Ghanem, Hutton, Zenilman, 
Zimba, & Erbelding, 2005; Gorbach et al., 2013; Kurth et al., 2004), or both (Turner et al., 
1998), compared to interviewer-administered methods.
Our interpretation of this finding is that the inhibiting effects of social desirability bias on 
risk behavior reporting in face-to-face interviews are context-dependent. In the present 
study, participants were young adults with high levels of drug use and sexual risk behaviors. 
Based on prior work (Kurtz et al., 2013; Kurtz, 2012), we believe that not-in-treatment 
persons with extensive drug involvement provide valid self-reports of risk behavior in face-
to-face interviews with non-judgmental interviewers because this information is not 
“sensitive” for them in these settings. Moreover, most of the research in the U.S. that 
supports the greater validity of ACASI over CAPI for collecting sensitive behavioral data is 
more than a decade old and included clinic-based samples. In terms of context, then, we 
postulate that we did not observe social desirability bias in the present study because of both 
participant and environmental factors: 1) young adults who participate in risky substance use 
and sexual behaviors with their peers may not perceive questions about sex or drug use to be 
stigmatizing; and 2) social desirability bias is muted in the presence of non-judgmental age-
peer interviewers who do not hold positions of clinical expertise or authority.
4.3. Limitations and strengths
Some limitations of our study merit attention. First, while our sample was representative of 
the gender and racial/ethnic composition of the region, it is unclear whether the study 
findings generalize to not-in-treatment young adult populations who use drugs in different 
contexts, have lower multi-drug use, or are engaged exclusively in same-sex behaviors. The 
sample recruited for this study exhibited very high levels of drug involvement and other 
health and social problems. Second, all data are based on self-report, and did not include 
drug use biomarkers. Given the high levels of substance use and sexual risk behaviors we 
found, however, as well as the consistency of reports across assessment modalities with 
random assignment, underreporting of stigmatized behaviors would appear to be minimal. 
Third, mental health symptoms were self-identified rather than assessed by a clinician, such 
that caution is warranted when comparing mental health symptomology reported here with 
other studies. However, there is evidence that young adults are the best informants of their 
internalizing behaviors (Pagano, Cassidy, Murphy, & Jellinek, 2000).
Fourth, we note that the ACASI assessment programming and setting we provided were 
highly structured, providing little opportunity for participants to “surf” through items and 
avoid meaningful responses (Ghanem et al., 2005). Finally, there is no perfect substitute for 
data collected directly from respondents, which were missing at baseline for secondary 
outcomes for control arm participants (who provided only drug use and sexual behavior 
frequency data at baseline). However, robust methods for multiple imputation generated 
baseline secondary outcome scores for controls that were comparable to the other arm 
conditions. Strengths of this study include a large and diverse sample of young adults with 
complex multidrug use, excellent balance of baseline characteristics across assigned 
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conditions, high retention rates, psychometrically sound measures, and statistical techniques 
that produced robust parameter estimates.
4.4 Implications for Future Research
We believe that the present study advances the science of behavioral intervention research 
among substance users in important ways. We demonstrated that, for the target population, 
assessment modality had no apparent inhibiting effect on the reporting of “sensitive” 
personal data, including drug use and sexual behaviors. Second, the study established the 
therapeutic benefit of interviewer interaction in reducing risky behavior among this young, 
club drug using population.
Third, and most importantly, we demonstrated the efficacy and acceptability of a low 
threshold intervention in reducing drug use, sexual risk behaviors and related co-morbidities 
among a not-in-treatment young adult population that exhibits severe and complex levels of 
drug use, but that is also highly resistant to intervention. Given the limited availability of 
substance abuse treatment slots for this population, and the comparative cost efficiencies of 
the assessment approach compared to formal treatment, future studies should prioritize 
testing the CAPI assessment intervention in community and clinical settings.
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Highlights
• Young adults in the club scene have intense and complex patterns of 
multidrug use.
• Assessments are effective interventions for young adults who use drugs.
• We found no social desirability bias differences in CAPI and ACASI 
modalities.
• The study found a therapeutic benefit of interviewer interaction.
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Figure I. Study Flow Chart
Kurtz et al. Page 19
J Subst Abuse Treat. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kurtz et al. Page 20
Ta
bl
e 
1
Ba
se
lin
e 
ch
ar
ac
te
ri
st
ic
s o
f y
o
u
n
g 
ad
ul
t m
ul
tid
ru
g 
us
er
s b
y 
in
te
rv
en
tio
n 
co
nd
iti
on
 (N
=
75
0)
D
em
og
ra
ph
ic
s
C
A
PI
 (N
=2
52
) N
 %
AC
A
SI
 (N
=2
46
) N
 %
C
on
tr
o
l (N
=
25
2) 
N 
%
F 
o
r 
X2
p
A
ge
 (y
ea
rs;
 M
,S
D)
25
.4
 (5
.5)
25
.1
 (5
.3)
25
.7
 (5
.3)
0.
9
0.
41
0
H
ig
h 
sc
ho
ol
 g
ra
du
at
ea
21
5 
(85
.3%
)
20
7 
(84
.1%
)
17
0 
(86
.7%
)
0.
6
0.
74
7
G
en
de
r m
al
e
13
6 
(53
.9%
)
14
0 
(56
.9%
)
14
5 
(57
.5%
)
0.
7
0.
69
8
R
ac
e/
et
hn
ic
ity
 
H
isp
an
ic
15
3 
(60
.7%
)
16
7 
(67
.8%
)
17
3 
(68
.6%
)
3.
5
0.
06
2
 
B
la
ck
63
 (2
5.0
%)
41
 (1
6.7
%)
49
 (1
9.4
%)
 
W
hi
te
26
 (1
0.3
%)
34
 (1
3.8
%)
27
 (1
0.7
%)
 
O
th
er
10
 (3
.9%
)
4 
(1.
6%
)
3 
(1.
2%
)
Su
bs
ta
nc
e u
se
 (p
as
t 9
0 d
ay
s)
A
lc
oh
ol
24
9 
(98
.8%
)
24
5 
(99
.6%
)
25
1 
(99
.6%
)
1.
6
0.
45
6
M
ar
iju
an
a
24
0 
(95
.2%
)
23
5 
(95
.5%
)
24
5 
(97
.2%
)
1.
5
0.
47
2
Co
ca
in
e 
(po
w
de
r)
23
4 
(92
.9%
)
22
7 
(92
.3%
)
23
2 
(92
.1%
)
0.
1
0.
94
1
Ec
st
as
y
24
2 
(96
.0%
)
24
0 
(97
.6%
)
24
4 
(96
.8%
)
0.
9
0.
62
5
LS
D
11
1 
(44
.1%
)
12
5 
(50
.8%
)
10
2 
(40
.3%
)
0.
6
0.
42
1
O
th
er
 h
al
lu
ci
no
ge
ns
13
7 
(54
.4%
)
14
1 
(57
.3%
)
12
2 
(48
.4%
)
1.
8
0.
18
1
M
et
ha
m
ph
et
am
in
e
59
 (2
3.4
%)
58
 (2
5.6
%)
50
 (1
9.8
%)
1.
3
0.
52
4
H
er
oi
n
52
 (2
0.6
%)
55
 (2
2.4
%)
57
 (2
2.6
%)
0.
3
0.
84
3
R
x 
be
nz
od
ia
ze
pi
ne
s
23
3 
(92
.5%
)
22
8 
(92
.7%
)
22
1 
(87
.7%
)
3.
4
0.
10
0
R
x 
op
io
id
s
22
5 
(89
.3%
)
22
1 
(89
.8%
)
21
6 
(85
.7%
)
2.
4
0.
29
7
R
x 
st
im
ul
an
ts
12
6 
(50
.0%
)
12
0 
(48
.8%
)
12
0 
(47
.6%
)
0.
3
0.
86
7
R
x 
an
tid
ep
re
ss
an
ts
66
 (2
6.2
%)
59
 (2
3.9
%)
63
 (2
5.0
%)
0.
3
0.
85
1
R
x 
an
tip
sy
ch
ot
ic
s
75
 (2
9.7
%)
63
 (2
5.6
%)
57
 (2
2.6
%)
3.
4
0.
18
5
Se
xu
al
 b
eh
av
io
rs
 (p
as
t 9
0 d
ay
s)
N
um
be
r o
f s
ex
 p
ar
tn
er
s (
M,
SD
)
7.
0 
(11
.4)
7.
2 
(15
.5)
6.
5 
(12
.6)
0.
2
0.
79
7
R
isk
y 
va
gi
na
l s
ex
14
7 
(58
.3%
)
14
1 
(57
.3%
)
15
1 
(59
.9%
)
0.
4
0.
83
7
R
isk
y 
an
al
 se
x
77
 (3
0.6
%)
63
 (2
5.6
%)
55
 (2
1.8
%)
5.
0
0.
08
1
J Subst Abuse Treat. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kurtz et al. Page 21
D
em
og
ra
ph
ic
s
C
A
PI
 (N
=2
52
) N
 %
AC
A
SI
 (N
=2
46
) N
 %
C
on
tr
o
l (N
=
25
2) 
N 
%
F 
o
r 
X2
p
C
om
or
bi
di
tie
s
Se
v
er
e 
m
en
ta
l d
ist
re
ss
a,
b
11
8 
(46
.8%
)
13
1 
(53
.5%
)
10
5 
(53
.6%
)
3.
7
0.
44
1
D
SM
-IV
 d
ep
en
de
nc
ea
,
b
16
8 
(66
.7%
)
17
1 
(69
.8%
)
13
8 
(70
.8%
)
3.
9
0.
41
1
Vi
ct
im
iz
at
io
n 
hi
sto
ry
a
19
5 
(77
.4%
)
16
6 
(67
.5%
)
15
6 
(80
.0%
)
0.
2
0.
70
1
Fi
rs
t a
bu
se
 b
ef
or
e 
ag
e 
18
a,
b
15
7 
(62
.3%
)
12
6 
(51
.2%
)
12
4 
(63
.6%
)
0.
1
0.
96
3
a N
ot
es
: 5
7 
co
nt
ro
ls 
m
iss
in
g 
da
ta
 (b
rie
f a
sse
ssm
en
t a
t b
ase
lin
e a
nd
 di
d n
ot 
co
mp
let
e t
he
 12
 m
on
th 
ass
ess
me
nt)
.
b O
ne
 A
CA
SI
 p
ar
tic
ip
an
t m
iss
in
g 
da
ta
.
J Subst Abuse Treat. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kurtz et al. Page 22
Ta
bl
e 
2
Ba
se
lin
e 
to
 1
2 
m
on
th
 c
ha
ng
e 
sc
or
es
 fo
r 
pr
im
ar
y 
an
d 
se
co
nd
ar
y 
ou
tc
om
es
O
ut
co
m
es
 (M
,S
D
)
BL
 (N
=
75
0)
3M
 (N
=
68
4)
6M
 (N
=
66
9)
12
M
 (N
=
60
2)
BL
-1
2M
ES
95
%
 C
I o
f E
S
Su
bs
ta
nc
e u
se
 (#
 d
ay
s i
n 
th
e 
pa
st
 9
0 
da
ys
)
 
Cl
ub
 d
ru
gs
 c
om
po
sit
e
CA
PI
12
8.
7 
(90
.8)
88
.9
 (8
3.5
)
76
.8
 (7
8.2
)
61
.3
 (7
7.1
)
-
62
.1
 (8
3.3
)
0.
89
*
*
*
*
0.
81
, 0
.9
7
A
CA
SI
12
9.
9 
(85
.3)
88
.5
 (7
9.9
)
71
.2
 (7
5.8
)
60
.0
 (7
2.4
)
-
65
.7
 (8
3.0
)
0.
82
*
*
*
*
0.
80
, 0
.9
7
Co
nt
ro
l
11
3.
8 
(83
.7)
94
.1
 (8
0.9
)
79
.6
 (7
5.7
)
65
.0
 (6
6.5
)
-
48
.2
 (6
6.8
)
0.
70
*
*
*
*
0.
60
, 0
.7
8
 
D
ay
s w
ith
ou
t d
ru
gs
 o
r 5
+ 
al
co
ho
lic
 d
rin
ks
CA
PI
9.
7 
(17
.0)
-
-
-
-
22
.7
 (3
0.7
)
12
.2
 (2
8.2
)
0.
41
*
*
*
0.
33
, 0
.4
8
A
CA
Sl
13
.1
 (1
6.9
)
-
-
-
-
19
.4
 (2
8.3
)
5.
9 
(28
.0)
0.
15
0.
06
, 0
.2
3
Co
nt
ro
l
11
.5
 (1
5.9
)
-
-
-
-
17
.0
 (2
5.6
)
5.
6 
(25
.4)
0.
09
0.
01
, 0
.2
1
Se
xu
al
 ri
sk
 b
eh
av
io
rs
 (p
as
t 9
0 d
ay
s)
 
R
isk
y 
va
g+
an
al
 se
x
 fr
eq
.
CA
PI
34
.2
 (5
0.4
)
22
.2
 (3
8.2
)
19
.5
 (3
7.0
)
17
.8
 (3
8.3
)
-
15
.4
 (4
8.5
)
0.
32
*
*
*
0.
29
, 0
.4
5
A
CA
Sl
36
.7
 (6
6.1
)
22
.2
 (3
9.5
)
22
.4
 (4
2.4
)
20
.0
 (5
3.9
)
-
14
.8
 (7
4.0
)
0.
20
*
0.
11
, 0
.2
9
Co
nt
ro
l
28
.8
 (4
3.3
)
18
.8
 (3
4.9
)
19
.9
 (3
3.0
)
19
.9
 (3
3.7
)
-
8.
4 
(41
.1)
0.
20
*
0.
12
, 0
.2
8
C
om
or
bi
di
tie
s
 
D
SM
-IV
 d
ep
en
de
nc
e 
sy
m
pt
om
s
CA
PI
3.
7 
(2.
3)
-
-
-
-
2.
4 
(2.
1)
-
1.
2 
(2.
2)
0.
54
*
*
*
*
0.
46
, 0
.6
1
A
CA
Sl
4.
0 
(2.
4)
-
-
-
-
2.
9 
(2.
2)
-
0.
9 
(2.
5)
0.
35
*
*
*
0.
27
, 0
.4
2
Co
nt
ro
l
3.
9 
(2.
1)
-
-
-
-
3.
6 
(2.
4)
-
0.
4 
(3.
3)
0.
12
0.
02
, 0
.2
2
 
M
en
ta
l d
ist
re
ss
 sy
m
pt
om
s
CA
PI
8.
0 
(7.
4)
-
-
-
-
5.
5 
(6.
7)
-
2.
1 
(6.
3)
0.
34
*
*
*
0.
27
, 0
.4
0
A
CA
Sl
8.
6 
(7.
4)
-
-
-
-
6.
6 
(6.
6)
-
1.
4 
(6.
0)
0.
22
*
*
0.
16
, 0
.2
8
Co
nt
ro
l
8.
5 
(6.
0)
-
-
-
-
8.
4 
(7.
2)
-
0.
1 
(8.
8)
0.
07
0.
02
, 0
.0
8
*
N
ot
es
: *
p<
.0
5,
*
*
p<
.0
1,
*
*
*
p<
.0
01
,
*
*
*
*
p<
.0
00
1;
 E
S=
ef
fe
ct
 si
ze
 d
J Subst Abuse Treat. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kurtz et al. Page 23
Ta
bl
e 
3
M
ul
til
ev
el
 m
od
el
 o
f l
on
gi
tu
di
na
l c
ha
ng
e 
in
 p
ri
m
ar
y 
an
d 
se
co
nd
ar
y 
ou
tc
om
es
 (N
=7
50
)
Va
ri
ab
le
C
lu
b 
D
ru
g 
co
m
po
sit
e f
re
qu
en
cy
R
isk
y 
va
gi
na
l s
ex
 +
 a
na
l s
ex
 fr
eq
ue
nc
y
D
ay
s w
ith
ou
t 5
+ 
A
/D
a
D
SM
-I
V
 D
ep
en
de
nc
e s
ym
pt
om
s
M
en
ta
l D
ist
re
ss
 s
ym
pt
om
s
β (
SE
)
F,
 p
β (
SE
)
F,
 p
P(
SE
)
F,
 p
β (
SE
)
F,
 p
β (
SE
)
F,
 p
A
ge
0.
0 
(0.
0)
0.
4
-
0.
0 
(0.
0)
0.
4
0.
0 
(0.
0)
3.
0
-
0.
8 
(0.
8)
1.
9
-
0.
0 
(0.
3)
0.
1
G
en
de
r m
al
e
0.
1 
(0.
1)
1.
5
-
0.
2 
(0.
2)
2.
5
-
0.
1 
(0.
1)
0.
2
0.
1 
(0.
2)
0.
2
0.
1 
(0.
1)
4.
0
R
ac
e 
(re
f B
lac
k)
1.
2
0.
4
1.
8
1.
8
0.
6
 
H
isp
an
ic
-
0.
1 
(0.
1)
-
0.
2 
(0.
2)
-
0.
0 
(0.
1)
-
0.
3 
(0.
2)
-
0.
1 
(0.
1)
 
W
hi
te
-
0.
4 
(0.
2)
-
0.
1 
(0.
1)
-
0.
1 
(0.
1)
-
0.
6 
(0.
3)
-
0.
1 
(0.
1)
 
Ot
he
r
-
0.
2 
(0.
2)
-
0.
7 
(0.
4)
-
0.
3 
(0.
2)
-
0.
8 
(0.
6)
-
0.
3 
(0.
2)
B
as
el
in
e 
va
lu
e
0.
9 
(0.
0)
65
9.
9*
*
*
*
0.
7 
(0.
1)
18
4.
2*
*
*
*
0.
3 
(0.
1)
47
.3
*
*
*
*
0.
3 
(0.
1)
47
.3
*
*
*
*
0.
4 
(0.
1)
12
2.
8*
*
*
*
Ti
m
e
-
0.
2 
(0.
1)
3.
0*
-
0.
2 
(0.
0)
2.
8
-
-
-
-
-
-
-
-
-
-
-
-
Ti
m
e 
^2
-
0.
0 
(0.
0)
0.
3
0.
0 
(0.
0)
4.
2*
-
-
-
-
-
-
-
-
-
-
-
-
A
rm
 (r
ef 
co
ntr
ol)
6.
1*
*
5.
7*
*
10
.8
*
*
*
*
11
.5
*
*
*
*
6.
8*
*
 
CA
PI
-
0.
4 
(0.
1)
-
0.
5 
(0.
2)
0.
2 
(0.
0)
-
1.
0 
(0.
2)
-
0.
3 
(0.
1)
 
A
CA
SI
-
0.
3 
(0.
1)
-
0.
1 
(0.
2)
0.
1 
(0.
0)
-
0.
6 
(0.
2)
-
0.
1 
(0.
1)
Ti
m
e 
× 
A
rm
-
0.
0 
(0.
1)
1.
1
0.
1 
(0.
2)
0.
3
-
-
-
-
-
-
-
-
-
-
-
-
Ef
fe
ct
 si
ze
 c
om
pa
ri
so
ns
 a
cr
o
ss
 c
o
n
di
tio
ns
 (d
=C
oh
en
's 
d)
CA
PI
 v
s. 
AC
A
SI
d=
0.
1
d=
0.
2*
d=
0.
3*
*
d=
0.
2*
d=
0.
2*
CA
PI
 v
s. 
Co
nt
ro
l
d=
0.
2*
*
d=
0.
3*
*
*
d=
0.
4*
*
*
*
d=
0.
4*
*
*
*
d=
0.
3*
*
*
A
CA
SI
 v
s. 
Co
nt
ro
l
d=
0.
2*
*
d=
0.
1
d=
0.
2*
d=
0.
2*
*
d=
0.
1
*
N
ot
es
: p
<
05
;
*
*
p<
01
;
*
*
*
p<
00
1;
*
*
*
*
p<
.0
00
1;
 β=
es
tim
at
e;
 S
E=
sta
nd
ar
d 
er
ro
r
J Subst Abuse Treat. Author manuscript; available in PMC 2018 July 01.
